Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A
Journal of Pharmacy & Pharmaceutical Sciences · 2025
DOI: 10.3389/jpps.2025.15553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, 2025. Verfasst von Elisabetta Esposito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Coumarins, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Despite the antioxidant, anti-inflammatory, and anti-cellular-aging activities of urolithin A (UroA), a naturally occurring postbiotic, its high lipophilicity hampers its pharmaceutical application. To overcome this limitation improving its stability and bioavailability, submicron emulsions (S-EMs) were designed.
Methods
Nineteen formulations (S-EM 1/S-EM 19) were prepared by two different methodologies. S-EMs were characterized evaluating macroscopical appearance and size distribution by photon correlation spectroscopy (PCS). One selected S-EM was loaded with UroA and characterized by PCS, transmission electron microscopy (TEM), small angle x-ray scattering (SAXS) and Fourier-transform infrared spectroscopy (FT-IR). Z potential, pH and syringeability were evaluated. UroA entrapment was studied efficiency by ultrafiltration and HPLC, while in vitro release by dialysis. Cytotoxicity was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) viability test on primary dermal human fibroblasts. The anti-inflammatory activity of S-EM-UroA was evaluated at 3, 6, and 24 h post-injection using the carrageenan-induced paw edema model in male C57BL/6 mice, and compared with UroA suspension and unloaded S-EM.
Results
The preformulative study enabled to select method and composition for S-EM preparation. S-EM 18 was selected for UroA loading (SEM-UroA), due to mean diameter, zeta potential, pH and syringeability suitable for intraperitoneal administration. The loading of UroA (0.2 mg/mL) did not influence S-EM physicochemical features, while maintaining technological properties for 3 months. In vitro drug release showed a biphasic profile, 2.35-fold faster in the case of SEM-UroA compared to the drug suspension. In vitro studies revealed absence of cytotoxicity at concentrations up to 5 µM. In vivo studies, conducted as a first step in assessing the potential of S-EM-UroA, demonstrated a dose-dependent anti-inflammatory effect. Specifically, S-EM-UroA at 2 mg/kg reduced paw edema at 24 h ( p < 00.5; One-Way ANOVA followed by Tukey’s test), and at 4 mg/kg significantly reduced edema at all time points ( p < 0.01), whereas the UroA suspension or S-EM had no effect on carrageenan-induced paw edema at any time point.
Conclusion
These findings underscore the potential of UroA loaded S-EM as an effective delivery system, demonstrating its superiority over simple UroA suspensions in enhancing the systemic anti-inflammatory effects of the postbiotic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
- Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy.
- Laboratory for Technologies of Advanced Therapies "LTTA"-Electron Microscopy Center, University of Ferrara, Ferrara, Italy.
- Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.
- Department of Neurosciences and Rehabilitation, University of Ferrara, Ferrara, Italy.
- Animal Science Department, Plants for Human Health Institute, NC State University, Kannapolis, NC, United States.
Zitieren
APA
Esposito, E., Dzyhovskyi, V., Santamaria, F., Marvelli, L., Boldrini, P., Mariani, P., Pepe, A., Ortore, M. G., Benedusi, M., Valacchi, G., & Ferraro, L. (2025). Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A. Journal of Pharmacy & Pharmaceutical Sciences. https://doi.org/10.3389/jpps.2025.15553
Vancouver
Esposito E, Dzyhovskyi V, Santamaria F, Marvelli L, Boldrini P, Mariani P, et al. Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A. Journal of Pharmacy & Pharmaceutical Sciences. 2025. doi:10.3389/jpps.2025.15553
BibTeX
@article{Esposito2025,
author = {Esposito, Elisabetta and Dzyhovskyi, Valentyn and Santamaria, Federico and Marvelli, Lorenza and Boldrini, Paola and Mariani, Paolo and Pepe, Alessia and Ortore, Maria Grazia and Benedusi, Mascia and Valacchi, Giuseppe and Ferraro, Luca},
title = {Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2025},
doi = {10.3389/jpps.2025.15553}
}
EUVIMED